Creating a new generation of biological therapeutics through advanced glycosylation technologies
Glythera Limited is a young spin-out biotechnology company from the University of Bath with core expertise in protein/peptide functionalisation and glycosylation technologies, imparting improved pharmacokinetic properties to biological therapeutics.
Glythera successfully raised its first round of investment in 2008, with research operations being conducted in dedicated laboratories situated on the campus of the University of Bath
Funding Rounds (2) - $3.93MUpdate
|Jun 21, 2012||Dow Jones Venture Wire - U.K.'s Glythera Collects First Tranche of GBP2M Round|
|Oct 10, 2010||FinSMEs - FinSMEs|
Newcastle Upon Tyne, NE1 7RU